Call 623-780-3540 | 3120 W. Carefree Highway, Suite 3 Phoenix, Arizona


What is RevitaLash?

RevitaLash ComboRevitaLash® is a cosmetic eyelash conditioner intended for use to “Enhance the Beauty of Your Natural Lashes.” The product is applied by a fine brush applicator to the base of the eyelashes once per day.

RevitaLash® is a remarkable cosmetic innovation that within weeks will help you achieve amazing looking eyelashes, appearing dramatically more beautiful: Longer, Thicker, Fuller…
Within weeks, your own natural eyelashes will look as though they had extensions!

Like liquid eyeliner, RevitaLash® is simply applied once-a-day to the base of the eyelashes. Within 60 days, your own natural eyelashes will look spectacular!

The Story

It all began when a Doctor wanted to give his wife a very special gift.

RevitaLash® was developed by Michael Brinkenhoff, M.D. as a special gift for his wife, Gayle, while she was recovering from metastatic breast cancer treatments. Intensive chemotherapy had damaged Gayle’s once-beautiful eyelashes, leaving them fragile, sparse and thin.

Based upon his knowledge and experience as a practicing ophthalmologist for over 25 years, Dr. Brinkenhoff believed that he could develop a formula that would give Gayle’s eyelashes the look of renewed health, strength and beauty.

After extensive research, Dr. Brinkenhoff, together with a talented team of cosmetic chemists, created a product that truly gave the beautiful look of renewed vitality to Gayle’s eyelashes. RevitaLash® was the perfect name for this amazing product!

Thus, an entirely new and unique cosmetic product was born; and a formula created originally for just one special lady has become a product available to men and women everywhere who want to have attractive, beautiful-looking eyelashes.

“Often we feel helpless when someone we love is suffering. I am very fortunate, in my own small way, to have been able to help Gayle through her recovery. Watching her be excited about her beautiful looking eyelashes has been a real joy.”

— Michael Brinkenhoff, M.D.